Article Details
Retrieved on: 2019-09-20 08:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Wedbush set a $191.00 target price on Ascendis Pharma A/S (NASDAQ:ASND) in a research report report published on Tuesday, TipRanks reports.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here